Delivery Order SPE2DB20D1004-SPE2DB24FG5V3

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NORVASC 5 MG TABLET 90S, a prescription medication, with a ceiling value of $1,392.17 and a performance period through June 30, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,093.44 firm-fixed-price contract is for the delivery of NORVASC 2.5 MG TABLET 90S, a cardiovascular medication. The contract is not set aside for any specific business type. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award, worth $4,652.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Norvasc 5 mg tablets, a cardiovascular medication, with a completion date of July 8, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,895.14 firm-fixed-price delivery order is for the supply of 4,565,597,451 units of the prescription drug Norvasc (amlodipine besylate) 5 mg tablets. The contract has an ultimate completion date of August 28, 2024 and does not utilize any set-aside designations. Amerisourcebergen is a major pharmaceutical distributor that...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $10,726.53 contract is for the supply of NORVASC 2.5 MG TABLET 90S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,167.46 firm fixed price delivery order is for the supply of NORVASC 5 MG TABLET 90S, a pharmaceutical product, in support of military treatment programs and facilities. The award is associated with a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA, valued at up to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical firm Amerisourcebergen Corporation. The $119,298.45 order is for the supply of Norvasc 10mg tablets to support DLA Troop Support Medical programs and facilities. As a prime contractor, Amerisourcebergen Drug Corp has an extensive history of providing a range of pharmaceutical products and medical supplies to the Department of Defense....
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,761.26 firm fixed-price contract is for the delivery of AMLODIPINE-VALSARTAN 5-320 MG 30S, a cardiovascular medication, and has an ultimate completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $7,193.12 firm fixed price award is for the supply of 100 units of the prescription drug Norvasc 5 mg tablets. This delivery order is part of Amerisourcebergen's larger indefinite delivery contract with DLA to provide pharmaceuticals and medical supplies in support of military treatment programs...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,588.22, is for the delivery of amlodipine-valsartan 5-160 mg tablets in 30-count packages. The contract has an ultimate completion date of March 19, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FG5V3
    Delivery Order

This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Norvasc 10 mg tablets, a cardiovascular medication, valued at $1,086.46. The order has an ultimate completion date of August 2, 2024 and is a Firm Fixed Price contract type. This Delivery Order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:25 AM